Silo Pharma executes 1-for-15 reverse stock split, reducing shares to 1.1M from 16.3M

Filed June 1, 2026 · Period ending June 1, 2026 · ~1 min read

Key Changes

• high

  Every 15 shares will consolidate into 1 share effective 4:01 p.m. ET on June 2, 2026, with post-split trading beginning June 3. Fractional shares will be rounded up to the next whole share.

  Item 5.03 view on EDGAR →
• high

  Outstanding common shares will decrease from approximately 16.267 million to approximately 1.084 million. The stock will continue trading under ticker symbol SILO on Nasdaq.

  Item 5.03 view on EDGAR →
• medium

  Authorized common stock will be proportionately reduced to 6,666,667 shares, maintaining the same ratio of authorized-to-outstanding shares as before the split.

  Item 5.03 view on EDGAR →